Publication | Closed Access

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial

Second-line TreatmentOncologyMetronomic TherapyClinical TrialsPathologyCancer TreatmentPhase 2Basket TrialMedicineRadiation OncologyLung CancerHealth Sciences